https://scientific-jl.com/luch/
Часть
-47
_ Том
-2_
июнь
-2025
281
SYMPTOMATIC THROMBOCYTOPATHY
Jakhonov Azizbek Kholmirzaevich
(Tashkent Medical Academy,
ALFRAGANUS UNIVERSITY)
Mamatkulova Dilrukh Fayzullayevna
(Center for Pediatric Hematology,
Oncology and Clinical Immunology)
Berdikobilova Mahliyo Khurshidovna
(City Clinical Children's Hospital
No. 3)
Shodmonqulova Marg'uba Kholmirzayevna
(City Clinical Children's
Hospital No. 3)
Title:
Clinical Manifestations, Diagnosis, and Management of Symptomatic
Thrombocytopathy
Abstract
Symptomatic thrombocytopathy refers to a group of disorders characterized
by abnormal platelet function, leading to bleeding and thrombotic complications.
Unlike thrombocytopenia, where platelet count is low, thrombocytopathy involves
normal or elevated platelet counts with impaired function. This condition can be
congenital or acquired, with various underlying causes including genetic mutations,
autoimmune diseases, and drug-induced effects. Patients often present with
mucocutaneous bleeding, easy bruising, and, paradoxically, thrombotic events such
as deep vein thrombosis or pulmonary embolism. Diagnosis involves platelet
function assays, bleeding time tests, and genetic screening. Management strategies
are tailored to the underlying etiology and may include platelet transfusions,
antifibrinolytic agents, or immunosuppressive therapy. Early recognition and
https://scientific-jl.com/luch/
Часть
-47
_ Том
-2_
июнь
-2025
282
appropriate treatment are crucial to prevent severe hemorrhagic or thrombotic
events.
Key Terms: Platelet dysfunction, bleeding disorders, thrombotic events,
congenital thrombocytopathy acquired thrombocytopathy, platelet punction assays,
antifibrinolytic therapy, immunosuppressive treatment, thrombocytopathy
diagnosis, hemostatic abnormalities.
1. Introduction
Platelets play a crucial role in hemostasis, and their dysfunction can lead to
significant bleeding or thrombotic complications. Symptomatic thrombocytopathy
encompasses disorders where platelets are present in normal or elevated numbers
but exhibit impaired function. This condition can be classified into congenital and
acquired forms, each with distinct etiologies and clinical presentations.
2. Classification and Etiology
2.1 Congenital Thrombocytopathy
Congenital thrombocytopathies are rare inherited disorders resulting from
genetic mutations affecting platelet function. These include defects in platelet
adhesion, aggregation, secretion, and signal transduction pathways. Examples
include Bernard-Soulier syndrome, Glanzmann thrombasthenia, and storage pool
disorders.
2.2 Acquired Thrombocytopathy
Acquired thrombocytopathies can result from various factors, including:
https://scientific-jl.com/luch/
Часть
-47
_ Том
-2_
июнь
-2025
283
•
Medications:
Aspirin, clopidogrel, and other antiplatelet drugs can
impair platelet function.
•
Autoimmune Diseases:
Conditions like systemic lupus
erythematosus can lead to the development of autoantibodies against platelet
receptors.
•
Uremia:
Chronic kidney disease can result in uremic toxins that
impair platelet function.
haematologica.org+1pubmed.ncbi.nlm.nih.gov+1
•
Liver Disease:
Severe liver dysfunction can lead to impaired synthesis
of clotting factors and platelet dysfunction.
3. Pathophysiology
The pathophysiology of symptomatic thrombocytopathy involves defects in
various platelet functions:
•
Adhesion:
Defective interaction between platelets and the
subendothelial matrix.
•
Aggregation:
Impaired platelet-to-platelet interaction, leading to
inadequate clot formation.
•
Secretion:
Defective release of granule contents, essential for platelet
activation and stabilization of the hemostatic plug.
•
Signal Transduction:
Altered intracellular signaling pathways
affecting platelet activation and function.
4. Clinical Manifestations
Patients with symptomatic thrombocytopathy may present with:
•
Mucocutaneous Bleeding:
Easy bruising, epistaxis, gum bleeding,
and menorrhagia.
https://scientific-jl.com/luch/
Часть
-47
_ Том
-2_
июнь
-2025
284
•
Post-Surgical Bleeding:
Excessive bleeding following minor surgical
procedures.
•
Thrombotic Events:
Paradoxical occurrence of thrombosis despite
bleeding tendencies.
•
Family History:
A positive family history may suggest a congenital
etiology.
5. Diagnostic Approach
Diagnosis of symptomatic thrombocytopathy involves:
•
Platelet Function Tests:
Assessing platelet aggregation, secretion,
and adhesion.
•
Bleeding Time:
Evaluating the time taken for bleeding to stop after a
standardized incision.
•
Genetic Testing:
Identifying mutations associated with congenital
disorders.
•
Platelet Count and Morphology:
Evaluating platelet number and
size.
6. Management Strategies
Management depends on the underlying etiology and may include:
•
Platelet
Transfusions:
Used
in
cases
of
severe
bleeding.
•
Antifibrinolytic Agents:
Such as tranexamic acid, to prevent
premature clot breakdown.
•
Immunosuppressive Therapy:
In cases of autoimmune-induced
thrombocytopathy.
https://scientific-jl.com/luch/
Часть
-47
_ Том
-2_
июнь
-2025
285
•
Avoidance of Antiplatelet Medications:
In acquired cases due to
drug-induced effects.
•
Gene Therapy:
Emerging treatment for certain congenital
disorders.
ncbi.nlm.nih.gov+1pmc.ncbi.nlm.nih.gov+1
7. Prognosis and Follow-Up
The prognosis varies depending on the severity of the disorder and the
effectiveness of treatment. Regular follow-up is essential to monitor for bleeding
or thrombotic complications and to adjust treatment as necessary.
8. Conclusion
Symptomatic thrombocytopathy is a complex group of disorders characterized
by platelet dysfunction. Early recognition and appropriate management are crucial
to prevent significant morbidity and mortality. Advancements in diagnostic
techniques and treatment options continue to improve patient outcomes.
9. References
1.
Kirchmaier CM, Pillitteri D. Diagnosis and management of inherited platelet
disorders. Transfus Med Hemother. 2010;37(5):237
–
246.
2.
Huebsch LB, Harker LA. Disorders of platelet function: mechanisms,
diagnosis, and management. West J Med. 1981;134(2):109
–
127.
3.
Shatzel JJ, Taylor JA. Syndromes of thrombotic microangiopathy. Med Clin
North Am. 2017;101(2):249
–
268.
4.
Chiasakul T, Cuker A. Clinical and laboratory diagnosis of thrombotic
thrombocytopenic purpura: an integrated approach. Hematology. 2018;23(1):1
–
9.
5.
StatPearls Publishing. Thrombotic thrombocytopenic purpura. [Online]
